Skip to Content


Dr. Hamilton Appointed to Becker Distinguished University Chair

Dr. Hamilton Appointed to Becker Distinguished University Chair
M. D. Anderson News Release 01/03/02

Dr. Stanley R. Hamilton, head of the Division of Pathology and Laboratory Medicine at The University of Texas M. D. Anderson Cancer Center, has been appointed to the Frederick F. Becker Distinguished University Chair for Cancer Research.

The $2 million endowment is the first Distinguished University Chair established at M. D. Anderson and is the highest level of endowed positions within The University of Texas System. 

Dr. Hamilton is an internationally recognized gastrointestinal pathologist and researcher in colorectal cancer and a leader in the rapidly expanding field of cancer genomics.  Dr. Becker is the former vice president for research at M. D. Anderson who helped lead the institution to international recognition in basic and translational research.

Dr. Hamilton established and now directs the Cancer Genomics Program at M. D. Anderson to support multidisciplinary research in understanding cancer at the genetic level.  The program includes a dedicated Cancer Genomics Core Laboratory, which is focusing on microarray technology to prepare in-house gene chips.  The program also supports development of a genomics database and an informatics working group to help in developing diagnostic tests and genetic profiles for counseling and prevention.

"I am honored to receive the first chair of this type at M. D. Anderson, especially because it is endowed in the name of a fellow pathologist who has contributed so much to the cancer center," Dr. Hamilton said.

"The benefit of endowed chairs to advances in cancer research is tremendous because these discretionary funds seed new projects and allow rapid development of new ideas and opportunities for research that can be funded later by the usual grant mechanisms," Dr. Hamilton said.

Dr. Hamilton serves on the editorial boards of three major professional journals and is a member of the Council of the American Society for Investigative Pathology and Board of Directors of the International Society of Gastroenterological Carcinogenesis. He is a member of the Board of Scientific Counselors of the National Cancer Institute and is co-editor of the World Health Organization Classification of Tumors of the Digestive System published last year.

Since 1998, Dr. Hamilton has headed the Division of Pathology and Laboratory Medicine at M. D. Anderson. Prior to joining M. D. Anderson, he was a member of the faculty in the Department of Pathology at The Johns Hopkins University School of Medicine and Hospital since 1979. He directed the Division of Gastrointestinal-Liver Pathology at Johns Hopkins for four years and remains widely recognized for his research activities that advanced molecular studies of colorectal cancer.

"I am enormously pleased that Stan Hamilton is the initial holder of my chair. He represents the future of pathology and cancer research, bringing the advances of macromolecular analysis to diagnosis and better understanding of disease processes," Dr. Becker said.

Funding for the chair was made available from various sources and numerous donors, including Charles Butt and H.E.B. of San Antonio; Robert J. Kleberg Jr. and Helen C. Kleberg Foundation of San Antonio; Sid W. Richardson Foundation of Fort Worth; and Raymond L. Golden of New York.


© 2015 The University of Texas MD Anderson Cancer Center